Your session is about to expire
← Back to Search
Other
Spinal Cord Stimulation for Phantom Limb Pain (PhantomLimb Trial)
N/A
Recruiting
Led By Lee E Fisher, PhD
Research Sponsored by Lee Fisher, PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have an upper-limb amputation
Be at least one year post-amputation
Must not have
Must not be currently taking any medications that thin your blood
Women who are pregnant or plan to become pregnant during the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a treatment for pain caused by amputation by electrical stimulation of the nerves in the spinal cord.
Who is the study for?
This trial is for adults aged 18-70 who have had an upper-limb amputation at least a year ago and can visit the University of Pittsburgh twice weekly for about a month. Pregnant women, those planning to become pregnant, individuals with serious health conditions, or those on blood thinners cannot participate.
What is being tested?
The study tests if electrical stimulation via electrodes placed near the spinal cord in the upper back and neck can produce sensations from the amputated limb and reduce phantom limb pain. The procedure involves multiple testing sessions over less than 30 days with temporary electrode placement.
What are the potential side effects?
While not explicitly stated, potential side effects may include discomfort at the electrode site, skin irritation, infection risk from implantation, and possible changes in sensation or pain levels during or after stimulation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have an amputation above the wrist.
Select...
It has been over a year since my amputation.
Select...
I am between 18 and 70 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not taking blood thinners.
Select...
I am not pregnant and do not plan to become pregnant during the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Stimulation thresholds to a variety of stimulus parameters
Secondary study objectives
Pain
Location and modality of evoked sensory percepts
Qualitative self-report of evoked sensations
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Boston Scientific cord stimulator leadExperimental Treatment1 Intervention
A Boston Scientific Stimulator Lead (PMA P030017) will be placed in the cervical epidural space of ten upper-limb amputees and steered laterally towards the dorsal spinal roots under fluoroscopic guidance.
Find a Location
Who is running the clinical trial?
Lee Fisher, PhDLead Sponsor
3 Previous Clinical Trials
55 Total Patients Enrolled
University of PittsburghLead Sponsor
1,789 Previous Clinical Trials
16,359,613 Total Patients Enrolled
Lee E Fisher, PhDPrincipal InvestigatorUniversity of Pittsburgh
1 Previous Clinical Trials
10 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not taking blood thinners.I do not have any serious illnesses that would prevent me from joining this study.I have an amputation above the wrist.It has been over a year since my amputation.I am not pregnant and do not plan to become pregnant during the study.I am between 18 and 70 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Boston Scientific cord stimulator lead
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger